Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 886982 NEW YORK, NY
Back to WHWK Full portfolio

Position in WHWK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$580,551
+$384,205 QoQ
Shares Held
126,758
+122.7% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 78 holders
Holding Since
Jun 2020
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WHWK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. WHWK ranks #277 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in WHWK

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $580,551 126,758
2026-03-31 $196,346 56,912
2024-06-30 $225,234 154,270
2024-03-31 $116,014 49,579
2023-06-30 $172,470 25,215
2023-03-31 $178,798 24,696
2022-12-31 $350,759 27,339
2022-09-30 $364,214 25,776
2022-06-30 $537,915 43,662
2022-03-31 $1,010,512 59,547